Journal Home
Search for

Volume 8, Issue 5, Pages 326-331 (September 2009)


View previous. 4 of 8 View next.

Intravenous peripherally-inserted central catheters for antibiotic therapy in children with cystic fibrosis

S. BuiaCorresponding Author Informationemail address, F. Babreb, S. Hauchecornea, N. Christofloura, F. Ceccatoa, V. Boisserie-Lacroixa, H. Clouzeaua, M. Fayona

Received 11 December 2008; received in revised form 8 July 2009; accepted 13 July 2009.

Abstract 

Background

We aimed to evaluate the use of central catheters introduced by a peripheral vein (PICC) in children with CF.

Methods

A descriptive study in patients in whom a PICC (Beckton Dickinson) was inserted.

Results

24 children aged (median (range) 10.2 years (0.3–17.3) undergoing 44 procedures were included. PICC was successfully inserted in 93.2% (41/44) of cases. Total procedure duration was (median (range)) 32.5 (10–105) minutes. The operators encountered few difficulties, median (range) 2 (1–10) (1 (absence) to 10 (maximal)); median (range) 1 (1 to 5) attempt per child). No major side effects or infections were observed. PICC obstruction in 5 (12%) cases was successfully unblocked in 4 cases (urokinase). The catheter was functional throughout the antibiotic course in 40/41 cases. A final Doppler scan (30 cases) showed total permeability of the central veins in all cases. Satisfaction index of the operators and the patients were high: median (range) 9.5 (1–10) and 8.0 (6–10) (scale: 1 (worse) to 10 (best)), respectively.

Conclusion

PICCs are simple to use, and may be safely inserted in the ward. Such catheters are well tolerated, may increase the well-being of children with CF and prove an effective means by which to deliver IV therapy in this population.

a CHU de Bordeaux, Hôpital Pellegrin-Enfants, CRCM Pédiatrique (Centre de Ressource et de Compétence en Mucoviscidose), F-33076 Bordeaux, France

b CHU de Bordeaux, Hôpital Pellegrin-Enfants, Department of Anaesthesia, F-33076 Bordeaux, France

Corresponding Author InformationCorresponding author. Tel.: +33 5 5 6 79 87 37; fax: +33 5 57 82 18 09.

 Presented in poster form at the 30th European Cystic Fibrosis Conference in Belek, Turkey, June 12 and 13, 2007.

PII: S1569-1993(09)00092-7

doi:10.1016/j.jcf.2009.07.002


View previous. 4 of 8 View next.